ARTICLE | Clinical News
Xarano: Commencing Phase III trials in the U.K.
August 16, 1993 7:00 AM UTC
Telor Ophthalmic Pharmaceuticals Inc. (TELR) Product: Xarano, a formulation of ethacrynic acid that promotes the outflow of fluid from the eye Indication: Control acute increases in intraocular pressu...